BLFS
Biolife Solutions Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$18.36
+0.21 ▲ +1.16%
🌙 3월 13일 6:42 PM ET (한국 3/14 07:42)
$18.17
-0.19 ▼ -1.03%
| Index | RUT | P/E | - | EPS (ttm) | -0.31 | Insider Own | 3.57% | Shs Outstand | 0.05B | Perf Week | -7.55% |
| Market Cap | 0.89B | Forward P/E | 53.77 | EPS next Y | 131.04% | Insider Trans | -37.74% | Shs Float | 0.05B | Perf Month | -17.48% |
| Enterprise Value | 0.82B | PEG | - | EPS next Q | 0.02 | Inst Own | 103.88% | Short Float | 6.43% | Perf Quarter | -25.88% |
| Income | -0.01B | P/S | 9.22 | EPS this Y | 159.11% | Inst Trans | 4% | Short Ratio | 7.3 | Perf Half Y | -31.34% |
| Sales | 0.10B | P/B | 2.38 | EPS next 5Y | - | ROA | -2.98% | Short Interest | 3.00M | Perf YTD | -24.07% |
| Book/sh | 7.72 | P/C | 9.97 | EPS past 3/5Y | 54.38% -55.02% | ROE | -3.37% | 52W High | -38.01% ($29.62) | Perf Year | -26.74% |
| Cash/sh | 1.84 | P/FCF | 83.34 | Sales past 3/5Y | -15.9% 14.88% | ROIC | -3.9% | 52W Low | 2.11% ($17.98) | Perf 3Y | -11.6% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -24.07% | Gross Margin | 64.29% | Volatility(W/M) | 6.03% 4.92% | Perf 5Y | -51.65% |
| Dividend TTM | - | EV/Sales | 8.48 | Sales Y/Y TTM | -15.11% | Oper. Margin | -17.26% | ATR (14) | 1.17 | Perf 10Y | 856.25% |
| Dividend Ex-Date | - | Quick Ratio | 4.63 | EPS Q/Q | -94.14% | Profit Margin | -15.51% | RSI (14) | 31.4 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.94 | Sales Q/Q | -17.29% | SMA20 | -13.77% ($21.29) | Beta | 2.01 | Target Price | $32.4 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2000000 | SMA50 | -19.6% ($22.84) | Rel Volume | 1.07 | Prev Close | $18.15 |
| Employees | 155 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 433.33% 2.85% | SMA200 | -23.8% ($24.09) | Avg Volume(3M) | 0.41M | Price | $18.36 |
| IPO | 1989/11/22 | Option/Short | Yes/Yes | Trades | 5978 | Volume | 439,702 | Change | 1.16% |
뉴스 로딩 중...